We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Seeking Clues to Corteva, Inc. (CTVA) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that Corteva, Inc. (CTVA - Free Report) will report quarterly earnings of $1.89 per share in its upcoming release, pointing to a year-over-year increase of 3.3%. It is anticipated that revenues will amount to $6.23 billion, exhibiting an increase of 1.9% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has undergone an upward revision of 3.1% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
In light of this perspective, let's dive into the average estimates of certain Corteva, Inc. metrics that are commonly tracked and forecasted by Wall Street analysts.
The average prediction of analysts places 'Revenue- Seed' at $4.46 billion. The estimate points to a change of +3.1% from the year-ago quarter.
Analysts expect 'Revenue- Crop Protection' to come in at $1.80 billion. The estimate points to a change of +1% from the year-ago quarter.
Analysts forecast 'Revenue- Crop Protection- Other' to reach $88.17 million. The estimate suggests a change of -48.1% year over year.
Analysts predict that the 'Revenue- Seed- Other' will reach $168.43 million. The estimate indicates a change of +16.2% from the prior-year quarter.
The combined assessment of analysts suggests that 'Revenue- Crop Protection- Herbicides' will likely reach $951.43 million. The estimate indicates a change of +0.6% from the prior-year quarter.
The consensus among analysts is that 'Revenue- Crop Protection- Insecticides' will reach $413.11 million. The estimate indicates a change of -0.5% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Revenue- Crop Protection- Fungicides' of $261.53 million. The estimate indicates a year-over-year change of +4.6%.
Analysts' assessment points toward 'Revenue- Seed- Soybean' reaching $1.31 billion. The estimate points to a change of -0.4% from the year-ago quarter.
The consensus estimate for 'Revenue- Seed- Corn' stands at $2.74 billion. The estimate indicates a year-over-year change of +2%.
It is projected by analysts that the 'Revenue- Seed- Other oilseeds' will reach $218.94 million. The estimate indicates a change of +17.7% from the prior-year quarter.
Based on the collective assessment of analysts, 'Operating EBITDA- Seed' should arrive at $1.77 billion. The estimate compares to the year-ago value of $1.70 billion.
According to the collective judgment of analysts, 'Operating EBITDA- Crop Protection' should come in at $249.65 million. Compared to the current estimate, the company reported $255.00 million in the same quarter of the previous year.
Corteva, Inc. shares have witnessed a change of -6.5% in the past month, in contrast to the Zacks S&P 500 composite's +2.3% move. With a Zacks Rank #3 (Hold), CTVA is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Seeking Clues to Corteva, Inc. (CTVA) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Wall Street analysts forecast that Corteva, Inc. (CTVA - Free Report) will report quarterly earnings of $1.89 per share in its upcoming release, pointing to a year-over-year increase of 3.3%. It is anticipated that revenues will amount to $6.23 billion, exhibiting an increase of 1.9% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has undergone an upward revision of 3.1% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
In light of this perspective, let's dive into the average estimates of certain Corteva, Inc. metrics that are commonly tracked and forecasted by Wall Street analysts.
The average prediction of analysts places 'Revenue- Seed' at $4.46 billion. The estimate points to a change of +3.1% from the year-ago quarter.
Analysts expect 'Revenue- Crop Protection' to come in at $1.80 billion. The estimate points to a change of +1% from the year-ago quarter.
Analysts forecast 'Revenue- Crop Protection- Other' to reach $88.17 million. The estimate suggests a change of -48.1% year over year.
Analysts predict that the 'Revenue- Seed- Other' will reach $168.43 million. The estimate indicates a change of +16.2% from the prior-year quarter.
The combined assessment of analysts suggests that 'Revenue- Crop Protection- Herbicides' will likely reach $951.43 million. The estimate indicates a change of +0.6% from the prior-year quarter.
The consensus among analysts is that 'Revenue- Crop Protection- Insecticides' will reach $413.11 million. The estimate indicates a change of -0.5% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Revenue- Crop Protection- Fungicides' of $261.53 million. The estimate indicates a year-over-year change of +4.6%.
Analysts' assessment points toward 'Revenue- Seed- Soybean' reaching $1.31 billion. The estimate points to a change of -0.4% from the year-ago quarter.
The consensus estimate for 'Revenue- Seed- Corn' stands at $2.74 billion. The estimate indicates a year-over-year change of +2%.
It is projected by analysts that the 'Revenue- Seed- Other oilseeds' will reach $218.94 million. The estimate indicates a change of +17.7% from the prior-year quarter.
Based on the collective assessment of analysts, 'Operating EBITDA- Seed' should arrive at $1.77 billion. The estimate compares to the year-ago value of $1.70 billion.
According to the collective judgment of analysts, 'Operating EBITDA- Crop Protection' should come in at $249.65 million. Compared to the current estimate, the company reported $255.00 million in the same quarter of the previous year.
View all Key Company Metrics for Corteva, Inc. here>>>Corteva, Inc. shares have witnessed a change of -6.5% in the past month, in contrast to the Zacks S&P 500 composite's +2.3% move. With a Zacks Rank #3 (Hold), CTVA is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .